Lisa Parfitt
- Bosentan in pulmonary hypertension associated with fibrotic idiopathic interstitial pneumonia: A randomized, double-blind, placebo-controlled studyBy Gregory Keir, Tamera Corte, Lisa Parfitt, Toby Maher, Phillip Marino, Elisabetta Renzoni, Konstantinos Dimopoulos, Michael Gatzoulis, Brendon Madden, Luke Howard, Paul Corris, Katherine O'Reilly, Ben Hope-Gill, Surinder Birring, Athol Wells and S. John WortGregory Keir1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomTamera Corte1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United Kingdom3Respiratory Medicine, Royal Prince Alfred Hospital, Sydney, AustraliaLisa Parfitt2National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomToby Maher1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomPhillip Marino2National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomElisabetta Renzoni1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomKonstantinos Dimopoulos2National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomMichael Gatzoulis2National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomBrendon Madden4Respiratory Medicine, St Georges Hospital, London, United KingdomLuke Howard5Respiratory Medicine, Hammersmith Hospital, London, United KingdomPaul Corris6Cardio-Pulmonary Unit, The Freeman Hospital, Newcastle upon Tyne, United KingdomKatherine O'Reilly8Respiratory Medicine, Southampton General Hospital, Southampton, United KingdomBen Hope-Gill9Respiratory Medicine, Llandough Hospital, Cardiff, United KingdomSurinder Birring7Respiratory Medicine, Kings College Hospital, London, United KingdomAthol Wells1Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomS. John Wort2National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United Kingdom
- Muscle function and physical activity in patients with idiopathic pulmonary arterial hypertension (IPAH)By Benjamin Garfield, Lisa Parfitt, Carl Harries, Philip Marino, Rafa Alonso-Gonzalez, Kostas Dimopoulos, Paul Kemp, Michael Polkey and S. John WortBenjamin Garfield1National Heart and Lung Institute, Imperial College, London, United Kingdom2Respiratory Medicine, Royal Brompton Hospital, London, United KingdomLisa Parfitt2Respiratory Medicine, Royal Brompton Hospital, London, United KingdomCarl Harries2Respiratory Medicine, Royal Brompton Hospital, London, United KingdomPhilip Marino2Respiratory Medicine, Royal Brompton Hospital, London, United KingdomRafa Alonso-Gonzalez2Respiratory Medicine, Royal Brompton Hospital, London, United KingdomKostas Dimopoulos2Respiratory Medicine, Royal Brompton Hospital, London, United KingdomPaul Kemp1National Heart and Lung Institute, Imperial College, London, United KingdomMichael Polkey1National Heart and Lung Institute, Imperial College, London, United Kingdom2Respiratory Medicine, Royal Brompton Hospital, London, United KingdomS. John Wort1National Heart and Lung Institute, Imperial College, London, United Kingdom2Respiratory Medicine, Royal Brompton Hospital, London, United Kingdom
- A retrospective study of depressive illness in patients with pulmonary hypertension (PH) at a specialist centreBy Lisa Parfitt, Philip Marino, Carl Harries, Kostas Dimopoulos and John WortLisa Parfitt1Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomPhilip Marino1Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomCarl Harries1Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomKostas Dimopoulos1Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomJohn Wort1Pulmonary Hypertension Service, Royal Brompton Hospital, London, United Kingdom
- Is sildenafil an effective bridging therapy to lung transplantation for patients with pulmonary hypertension in the setting of lung disease?By Laura Price, Aleksander Kempny, Kostantinos Dimopoulos, Raphael Alonso, Lisa Parfitt, Carl Harries, Martin Carby, Andre Simon, Athol Wells, John Wort and Anna ReedLaura Price1National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomAleksander Kempny1National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomKostantinos Dimopoulos1National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomRaphael Alonso1National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomLisa Parfitt1National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomCarl Harries1National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomMartin Carby2Transplantation Service, Harefield Hospital, London, Uxbridge United KingdomAndre Simon2Transplantation Service, Harefield Hospital, London, Uxbridge United KingdomAthol Wells3Interstitial Lung Disease Unit, Royal Brompton Hospital, London, United KingdomJohn Wort1National Pulmonary Hypertension Service, Royal Brompton Hospital, London, United KingdomAnna Reed2Transplantation Service, Harefield Hospital, London, Uxbridge United Kingdom
- Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severityBy Beatriz Garcia-Aranda, Aleksander Kempny, Marina Revilla-Martinez, Carl Harries, Lisa Parfitt, Rafael Alonso-Gonzalez, Laura Price, Konstatinos Dimopoulos and John WortBeatriz Garcia-Aranda1Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom2NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, United KingdomAleksander Kempny1Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom2NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, United KingdomMarina Revilla-Martinez3Cardiology, Universitary Hospital Rio Hortega, Valladolid, SpainCarl Harries1Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom2NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, United KingdomLisa Parfitt1Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom2NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, United KingdomRafael Alonso-Gonzalez1Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom2NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, United KingdomLaura Price1Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom2NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, United KingdomKonstatinos Dimopoulos1Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom2NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, United KingdomJohn Wort1Adult Congenital Heart Centre and Centre for Pulmonary Hypertension, Royal Brompton Hospital, London, United Kingdom2NIHR Cardiovascular Biomedical Research Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom
- The role of growth and differentiation factor 15 (GDF-15) in the development of skeletal muscle wasting in pulmonary arterial hypertension (PAH)By Benjamin Garfield, Alexi Crosby, Yang Pieran, Lee Jen, Dongmin Shao, Lisa Parfitt, Carl Harries, Nicholas Morrell, Michael' Polkey, Paul Kemp and S. John WortBenjamin Garfield1National Heart and Lung Institute, Imperial College London, London, United Kingdom2Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United KingdomAlexi Crosby3Medicine, University of Cambridge, Cambridge, United KingdomYang Pieran3Medicine, University of Cambridge, Cambridge, United KingdomLee Jen1National Heart and Lung Institute, Imperial College London, London, United KingdomDongmin Shao1National Heart and Lung Institute, Imperial College London, London, United KingdomLisa Parfitt2Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United KingdomCarl Harries2Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United KingdomNicholas Morrell3Medicine, University of Cambridge, Cambridge, United KingdomMichael' Polkey1National Heart and Lung Institute, Imperial College London, London, United Kingdom2Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United KingdomPaul Kemp1National Heart and Lung Institute, Imperial College London, London, United KingdomS. John Wort1National Heart and Lung Institute, Imperial College London, London, United Kingdom2Respiratory Medicine, Royal Brompton and Harefield NHS Foundation Trust, London, United Kingdom
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.